Maier, Leonie
Benzinger, Petra
Abel, Bastian
Roigk, Patrick
Bongartz, Martin
Wirth, Isabel
Cuvelier, Ingeborg
Schölch, Sabine
Büchele, Gisela
Deuster, Oliver
Bauer, Jürgen
Rapp, Kilian
Ullrich, Charlotte
Wensing, Michel
Roth, Catharina
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 16 May 2024
Accepted: 12 July 2024
First Online: 31 July 2024
Declarations
:
: The authors declare that they have no competing interests.
: The study protocol has been approved by two different ethics committees, as different ethics committees have been responsible for each of the study sites. The Ethics Committee of the Medical Faculty of Heidelberg University approved the study protocol for the consortium-leading study site AGAPLESION BETHANIEN HOSPITAL HEIDELBERG (approval # S-395/2022), whereas the Ethics Committee of the State Medical Association Baden-Wurttemberg has approved the study protocol for the study sites Robert-Bosch-Hospital Stuttgart and ViDia Christian Clinics Karlsruhe (approval # B-F-2022-057). All procedures in this study involving human participants are in accordance with the recent version of the Declaration of Helsinki. All participants are covered by an insurance while participating in the study. Substantial amendments to the protocol are submitted for approval to the ethical committees and communicated to the trial registry. Written informed consent for audio recording the interviews was provided prior to the interview by participants.